Literature DB >> 17202395

Effects of feeding Salmonella enterica serovar Typhimurium or serovar Choleraesuis on growth performance and circulating insulin-like growth factor-I, tumor necrosis factor-alpha, and interleukin-1beta in weaned pigs.

J N Fraser1, B L Davis, K A Skjolaas, T E Burkey, S S Dritz, B J Johnson, J E Minton.   

Abstract

The most common Salmonella serovars causing clinical disease in pigs are Salmonella enterica serovars Typhimurium (Typhimurium) and Choleraesuis. Given that the swine host-adapted serovar Choleraesuis has been reported to cause systemic disease, a different disease outcome from that of Typhimurium, our working hypothesis was that this serovar would likely engage systemic immune-inflammatory mechanisms, resulting in elevated systemic cytokine secretion. Forty-eight weaned pigs were blocked by BW and sex, and randomly allotted to 1 of 3 treatments in a 14-d study. Each treatment had 8 replicates (pens), with 2 pigs/pen. The treatments consisted of a negative control and pigs repeatedly fed 10(8) cfu of Typhimurium or Choleraesuis. On d 0, the pigs were fed Choleraesuis or Typhimurium in dough balls, and the bacteria were refed twice weekly throughout the experiment. Control pigs received dough balls without bacteria. All pigs were housed in temperature-controlled rooms under constant lighting and were fed a standard corn-soybean meal-based nursery diet. Pig BW and feed disappearance were used to determine ADG, ADFI, and G:F. Rectal temperatures were obtained daily from 1 pig/pen beginning 2 d before the first bacterial feeding through d 7 using rapid-response digital thermometers. Serum was collected on d 0, 7, and 14 from a single pig/pen for analysis of IGF-I, tumor necrosis factor-alpha , and IL-1beta. There was no change in the rectal temperature of the control or the Typhimurium-challenged pigs (compared with d 0) or when comparing Typhimurium-challenged pigs with control animals. In contrast, pigs fed Choleraesuis had increased rectal temperatures beginning on d 2 and continuing through d 7 (P < 0.05), with the greatest elevation on d 3 (P < 0.001) compared with the control pigs. Average daily gain and ADFI of pigs challenged with Typhimurium did not differ from those of the control animals. Pigs fed Choleraesuis had a 25% reduction in ADG (P < 0.0001) and ADFI (P < 0.002) compared with the control pigs. On d 7, pigs fed Choleraesuis had reduced serum IGF-I compared with control (P < 0.01) or Typhimurium-challenged pigs (P = 0.01). Bacterial feeding did not affect serum tumor necrosis factor-alpha or IL-1beta compared with control pigs at any time throughout the experiment. We conclude that repeated exposure of weaned pigs to Choleraesuis reduced growth performance in the absence of changes in systemic inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17202395     DOI: 10.2527/jas.2006-482

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  4 in total

1.  Salmonella Typhimurium lacking the Znuabc transporter is attenuated and immunogenic in pigs.

Authors:  M Pesciaroli; M Gradassi; N Martinelli; J Ruggeri; C Pistoia; M Raffatellu; C F Magistrali; A Battistoni; P Pasquali; G L Alborali
Journal:  Vaccine       Date:  2013-04-24       Impact factor: 3.641

2.  A clinical field trial to evaluate the efficacy of vaccination in controlling Salmonella infection and the association of Salmonella-shedding and weight gain in pigs.

Authors:  Abdolvahab Farzan; Robert M Friendship
Journal:  Can J Vet Res       Date:  2010-10       Impact factor: 1.310

3.  Blood concentrations of the cytokines IL-1beta, IL-6, IL-10, TNF-alpha and IFN-gamma during experimentally induced swine dysentery.

Authors:  Robert Kruse; Birgitta Essén-Gustavsson; Caroline Fossum; Marianne Jensen-Waern
Journal:  Acta Vet Scand       Date:  2008-08-12       Impact factor: 1.695

Review 4.  Infection, immunity and the neuroendocrine response.

Authors:  Paolo Borghetti; Roberta Saleri; Eugenio Mocchegiani; Attilio Corradi; Paolo Martelli
Journal:  Vet Immunol Immunopathol       Date:  2009-02-04       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.